Risk Factors for Staphylococcus Aureus Surgical Site Infections in Orthopedic and Trauma Surgery (ISO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03040960 |
Recruitment Status : Unknown
Verified October 2017 by University Hospital, Grenoble.
Recruitment status was: Recruiting
First Posted : February 2, 2017
Last Update Posted : October 11, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Staphylococcus Aureus Surgical Wound Infection Orthopedic Disorder Traumatology |
Surgical site infections (SSI) in orthopedic surgery are responsible for reduced quality of life, increased length of hospital stay and costs. The most commonly identified organism is Staphylococcus aureus but risk factors for mono microbial S.aureus SSI are not well-known.The aim of this study was to evaluate the incidence rate trend of S. aureus SSI over the years and risk factors of theses infections in a french University Hospital.
The knowledge obtained by this study will enable identification of the surgical patients most at risk of developping S. aureus SSI, and who would probably benefit most from new interventions given prophylactically and specifically to prevent S. aureus infections.
Study Type : | Observational |
Estimated Enrollment : | 150 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Risk Factors for Staphylococcus Aureus Surgical Site Infections in Orthopedic and Trauma Surgery |
Study Start Date : | August 2016 |
Estimated Primary Completion Date : | August 2018 |
Estimated Study Completion Date : | August 2018 |

- Risk factors of S. aureus surgical site infections. [ Time Frame: up to 1 year following surgery ]univariate analysis of potential risk factors. Data with p value less than 0.1 were included in a logistic regression model
- The incidence rate trend of S. aureus SSI over the year. [ Time Frame: from january 1st 2012 to april 30th 2015 ]linear regression slope test of S. aureus SSI incidence rates by years

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- orthopedic or traumatology surgeries performed in Grenoble University Hospital,
- from january 1st 2012 to april 30th 2015,
- the subject is undergoing one of the following surgical procedures : knee and hip arthroplasties, osteosynthesis of proximal femur and other osteosynthesis except skull and spine.
- the subject is 16 years of age or older
Exclusion Criteria:
- non orthopedic or trauma surgery performed in Grenoble University Hospital,
- spine surgeries,
- surgeries of the hand, scaphoid and carpal bones.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03040960
Contact: Caroline Landelle, PH | 0033476765643 | clandelle@chu-grenoble.fr |
France | |
University Hospital, Grenoble Alpes | Recruiting |
Grenoble, France, 38043 | |
Contact: Caroline Landelle 0033476765643 clandelle@chu-grenoble.fr |
Principal Investigator: | Caroline landelle, PH | University Hospital, Grenoble |
Responsible Party: | University Hospital, Grenoble |
ClinicalTrials.gov Identifier: | NCT03040960 |
Other Study ID Numbers: |
38RC16.223 1985246 ( Other Identifier: CNIL ) |
First Posted: | February 2, 2017 Key Record Dates |
Last Update Posted: | October 11, 2017 |
Last Verified: | October 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
infection wound infection surgical wound infection Staphylococcal infections |
wound and injuries postoperative complications Gram-positive bacterial infections bacterial infections |
Infection Communicable Diseases Surgical Wound Infection Wound Infection Musculoskeletal Diseases |
Surgical Wound Postoperative Complications Pathologic Processes Wounds and Injuries |